Founder first
Just In
Brands
Resources
Events
In an interview with EnterpriseStory, Karan Dhundia, Regional Managing Principal at ZS, says that as pharma moves beyond AI pilots, the focus is shifting to scaling the technology across operations while ensuring measurable business outcomes, responsible adoption, and effective governance.
Pharma moves AI from pilots to enterprise: 50% of Indian firms invest, 25% running GenAI in production. Real challenge is embedding AI into daily operations—governance and organizational change matter more than technology for measurable scale and ROI.
Founder first
Just In
Brands
Resources
Events

UPMC, KLAS Research study examines AI adoption trends, governance barriers

Pharma’s AI Inflection Point: Five Lessons For CAIOs

The AI boom could strengthen Epic's position, health system execs say. Here's where startups and health tech vendors can still win